Clinical trials involving individuals with overweight and obesity who were treated with a long‐acting GDF15 receptor analogue showed a reduction in food intake and body weight, supporting the weight‐reducing effect of GDF15 (Benichou et al., 2023). This evidence concerns the gene GDF15 and obesity due to melanocortin 4 receptor deficiency.